<DOC>
	<DOCNO>NCT00697515</DOCNO>
	<brief_summary>To evaluate efficacy LDX compare placebo adult ADHD adult workplace environment ( AWE ) set</brief_summary>
	<brief_title>Safety Efficacy Workplace Environment Study Lisdexamfetamine Dimesylate ( LDX ) Adults With Attention-Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>This study optimization double-blind period</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Subject must 1855 year age , inclusive time consent . Female subject must negative serum beta Human Chorionic Gonadotropin ( HCG ) pregnancy test Screening negative urine pregnancy test Baseline agree comply applicable contraceptive requirement protocol . Subject meet Diagnostic Statistical Manual Mental Disorders Fourth Edition ; Text Revision ( DSM IV TR ) criteria primary diagnosis ADHD ( diagnostic code 314.00 314.01 ) establish comprehensive psychiatric evaluation review DSMIVTR criterion least 6 9 subtype criterion meet . The Adult ADHD Clinical Diagnostic Scale version 1.2 ( ACDS v1.2 ) utilize diagnostic tool . Subject Baseline score &gt; equal 28 use Adult ADHDRS prompt . Subject must minimum level intellectual functioning , determine Intelligent Quotient ( IQ ) score 80 base Kaufman Brief Intelligence Test ( KBIT ) . Subject current comorbid psychiatric disorder either control medication prohibit study uncontrolled associate significant symptom . Comorbid psychiatric diagnosis establish psychiatric evaluation include Structured Clinical Interview DSMIVTR disorder ( SCIDI ) . Subjects currently consider suicide risk , subject previously make suicide attempt currently demonstrate active suicidal ideation . Subject history seizure ( infantile febrile seizure ) , tic disorder , current diagnosis and/or know family history Tourette 's Disorder . Subject known history symptomatic cardiovascular disease , advanced arteriosclerosis , structural cardiac abnormality , cardiomyopathy , serious heart rhythm abnormality , coronary artery disease , transient ischemic attack stroke serious cardiac problem may place increased vulnerability sympathomimetic effect stimulant drug . Subject current abnormal thyroid function , define abnormal Screening thyroid stimulate hormone . Treatment stable dose thyroid medication least 3 month permit . Subject history moderate severe hypertension rest sit systolic blood pressure &gt; 139mmHg diastolic blood pressure &gt; 89mmHg . Subject document allergy , hypersensitivity , intolerance amphetamine . Subject fail respond one adequate course ( dose duration ) amphetamine therapy . Subject glaucoma . Subject take medication central nervous system ( CNS ) effect affect performance , sedate antihistamine decongestant sympathomimetics , monoamine oxidase inhibitor ( within 14 day test reference product administration ) . Stable use bronchodilator inhaler exclusionary . Subject female pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>